Speakers

Dr. Antoine Thomas is a CMC expert with +17 years’ experience in the pharmaceutical industry spanning from early to late phase development of small molecules, biologicals and gene therapy products. Antoine is currently Head of External Manufacturing of ExeVir Bio a spin out of the VIB (Vlaams Instituut voor Biotechnologie, Belgium) developing single domain antibodies against viral infections. He formally was Sr. CMC Manager at Vivet Therapeutics a French start-up company dedicated to developing gene therapy treatments for orphan diseases. He joined Vivet from Ablynx (now Ablynx a Sanofi company) where he led the Caplacizumab (Cablivi®) CMC development program till BLA/MAA submission. Before that position he had been working at UCB-Pharma as Group Leader working on the manufacturing process development and alternative synthetic routes of Brivaracetam (Briviact®). Antoine holds a PhD in Organic Chemistry from the Université Henri Poincaré Nancy 1 (FR).

Presentation Title: External Manufacturing Solutions to Accelerate Covid-19 Therapeutic Antibody Development

View company profile